Fig. 3: Proportion treated and average benefit among those recommended for azithromycin under the comprehensive rule with varying thresholds of clinical benefit to define the rule. | Nature Communications

Fig. 3: Proportion treated and average benefit among those recommended for azithromycin under the comprehensive rule with varying thresholds of clinical benefit to define the rule.

From: Personalized azithromycin treatment rules for children with watery diarrhea using machine learning

Fig. 3

A Proportion treated and average benefit across thresholds for diarrhea on day 3; B Proportion treated and average benefit across thresholds for re-hospitalization or death by day 90; C Proportion treated and average benefit across thresholds for change in linear growth. The 95% confidence intervals are represented by the grey dotted lines with shaded bands, and the sample size for each treatment benefit estimation is determined by the proportion of n = 6692 treated under each threshold. RD Risk difference, CI Confidence interval, LAZ Length-for-age Z-score. Source data are provided as a Source Data File on Github.

Back to article page